These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 9544741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A, Wang Y, Stienstra R, Tjeerdema N, Janssen A, Stalenhoef A, van der Vliet JA, de Roos A, Tamsma JT, Smit JW, Tan NS, Müller M, Rensen PC, Kersten S.
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
    Purcell-Huynh DA, Farese RV, Johnson DF, Flynn LM, Pierotti V, Newland DL, Linton MF, Sanan DA, Young SG.
    J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.
    Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL.
    J Biol Chem; 2002 Oct 11; 277(41):38517-23. PubMed ID: 12145296
    [Abstract] [Full Text] [Related]

  • 11. Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice.
    Staprans I, Pan XM, Rapp JH, Grunfeld C, Feingold KR.
    Arterioscler Thromb Vasc Biol; 2000 Mar 11; 20(3):708-14. PubMed ID: 10712395
    [Abstract] [Full Text] [Related]

  • 12. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
    Verschuren L, Kleemann R, Offerman EH, Szalai AJ, Emeis SJ, Princen HM, Kooistra T.
    Arterioscler Thromb Vasc Biol; 2005 Jan 11; 25(1):161-7. PubMed ID: 15514207
    [Abstract] [Full Text] [Related]

  • 13. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
    van Vlijmen BJ, van Dijk KW, van't Hof HB, van Gorp PJ, van der Zee A, van der Boom H, Breuer ML, Hofker MH, Havekes LM.
    J Biol Chem; 1996 Nov 29; 271(48):30595-602. PubMed ID: 8940032
    [Abstract] [Full Text] [Related]

  • 14. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Mar 01; 97(5):1184-92. PubMed ID: 8636429
    [Abstract] [Full Text] [Related]

  • 15. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage.
    Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, Wellens H, de Muinck ED.
    Circulation; 1999 Jan 19; 99(2):276-83. PubMed ID: 9892595
    [Abstract] [Full Text] [Related]

  • 16. Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions.
    de Vries HE, Buchner B, van Berkel TJ, Kuiper J.
    Arterioscler Thromb Vasc Biol; 1999 Mar 19; 19(3):638-45. PubMed ID: 10073968
    [Abstract] [Full Text] [Related]

  • 17. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM.
    J Clin Invest; 1995 Sep 19; 96(3):1639-46. PubMed ID: 7657833
    [Abstract] [Full Text] [Related]

  • 18. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
    Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE.
    J Clin Invest; 1995 Nov 19; 96(5):2170-9. PubMed ID: 7593602
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.